New Drug For Clotting Has Roots In Oklahoma

Thursday, May 3rd 2007, 3:21 pm
By: News On 6

OKLAHOMA CITY (AP) -- A new drug being used to treat a rare but life-threatening genetic disorder was developed from early scientific discoveries at the Oklahoma Medical Research Foundation nearly 20 years ago.

The drug Ceprotin is now being used to treat patients with severe congenital Protein C deficiency. Those patients suffer unusually high numbers of blood clots in the skin, eyes, brain and kidneys.

OMRF officials say the drug is related to discoveries made in the late 1980s by husband and wife scientists Charles and Naomi Esmon.

OMRF filed for patents on the discoveries in 1988 and the patents were issued in 1993 and '94.